Starling Oncology, Inc. Goodwill, Acquired During Period
Starling Oncology, Inc. (STLN) reported Goodwill, Acquired During Period of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-26.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2025-03-26
- Starling Oncology, Inc. goodwill, acquired during period for the quarter ending 2024-12-31 was $0.00.
- Starling Oncology, Inc. goodwill, acquired during period for the quarter ending 2024-09-30 was $0.00.
- Starling Oncology, Inc. goodwill, acquired during period for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. goodwill, acquired during period for the quarter ending 2024-03-31 was $0.00.
- Starling Oncology, Inc. goodwill, acquired during period for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Starling Oncology, Inc. goodwill, acquired during period for fiscal 2023 was $2.68M, a 43.43% decline from fiscal 2022.
- Starling Oncology, Inc. goodwill, acquired during period for fiscal 2022 was $4.74M, a 61.80% decline from fiscal 2021.
- Starling Oncology, Inc. goodwill, acquired during period for fiscal 2021 was $12.40M, a 8166.00% increase from fiscal 2020.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $0.00 derived: sum of 2 quarters · filed 2025-03-26 | $0.00 derived: sum of 3 quarters · filed 2025-03-26 | $0.00 10-K · filed 2025-03-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | $0.00 derived: sum of 4 quarters · filed 2025-03-26 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | $0.00 derived: sum of 3 quarters · filed 2025-03-26 | $0.00 derived: sum of 4 quarters · filed 2025-03-26 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | $0.00 derived: sum of 2 quarters · filed 2025-03-26 | $0.00 derived: sum of 3 quarters · filed 2025-03-26 | $2.68M derived: sum of 4 quarters · filed 2025-03-26 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $0.00 derived: sum of 2 quarters · filed 2025-03-26 | $2.68M derived: sum of 3 quarters · filed 2025-03-26 | $2.68M 10-K · filed 2025-03-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $2.68M derived: sum of 2 quarters · filed 2023-11-08 | $2.68M 10-Q · filed 2023-11-08 | -$2.63M derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-06-30 | $2.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.68M 10-Q · filed 2023-08-09 | -$2.63M derived: sum of 3 quarters · filed 2024-03-28 | -$435.00K derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | -$5.30M derived: sum of 2 quarters · filed 2024-03-28 | -$3.11M derived: sum of 3 quarters · filed 2024-03-28 | $4.74M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-12-31 | -$5.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$3.11M derived: sum of 2 quarters · filed 2024-03-28 | $4.74M derived: sum of 3 quarters · filed 2024-03-28 | $4.74M 10-K · filed 2024-03-28 |
| 2022-09-30 | $2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $10.04M derived: sum of 2 quarters · filed 2022-11-09 | $10.04M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $7.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $7.85M 10-Q · filed 2022-08-09 | ||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | $12.40M 10-K · filed 2023-03-16 | |||
| 2020-12-31 | $150.00K 10-K · filed 2022-03-11 |